What the Retatrutide Calculator does

Retatrutide is supplied for research use as a lyophilised (freeze-dried) powder measured in milligrams. A syringe, however, measures volume — millilitres or the unit markings printed on an insulin syringe. The retatrutide calculator on this page bridges those two units. It takes the milligrams in the vial and the millilitres of diluent added, derives the resulting concentration in mg/mL, and then converts any milligram figure you enter into the corresponding volume and syringe-unit equivalent.

It also answers two questions people usually work out on paper: how many equal portions of a given size a vial contains, and how much material and liquid remain after a chosen number of those portions have been withdrawn. Every output is shown alongside the arithmetic that produced it, so nothing is a black box — you can reproduce each number with a pocket calculator.

This is a mathematics tool. It contains no dosing table, no titration schedule and no suggestion about what any individual should use. Retatrutide is an investigational compound that has not been approved by the FDA or any comparable regulator, so no legitimate consumer dosing guidance exists to give.

How to use the calculator

Vial amount (mg). Enter the total milligrams stated on the vial label — commonly 5, 10, 15, 20 or 30 mg for retatrutide vials. Do not enter the amount you intend to measure here.
Reconstitution volume (mL). Enter the volume of diluent you actually added, typically bacteriostatic water. This single number controls the concentration of everything that follows.
Desired amount (mg). Enter the milligram figure you want to convert into a volume. The calculator flags an error if this exceeds the total in the vial.
Syringe size (mL). Choose 0.3 mL (30 units), 0.5 mL (50 units) or 1 mL (100 units). If the required volume will not fit in one draw, the calculator says so explicitly instead of silently returning an impossible number.
Portions already drawn. Optional. Enter how many equal portions have already been removed to see what is left, in both mg and mL.

Results recalculate as you type. Copy results puts the full calculation, including the inputs, on your clipboard, and Reset returns every field to its starting value.

What retatrutide concentration means

Concentration expresses how much peptide is dissolved in each millilitre of liquid, written as mg/mL. A vial does not have a concentration until it is reconstituted: 10 mg of dry powder is just 10 mg. Once you add 2 mL of bacteriostatic water, that same 10 mg is distributed through 2 mL, giving 5 mg/mL. Add 4 mL instead and the identical vial becomes 2.5 mg/mL.

This is why two people holding identical retatrutide vials can need completely different volumes to measure the same milligram figure. The milligrams in the vial are fixed; the concentration is a choice made at reconstitution. A more dilute solution needs a larger, easier-to-read volume on the syringe; a more concentrated solution needs a smaller volume, where a small reading error represents a larger proportional error.

How mg/mL is calculated

The concentration formula is a single division:

Concentration (mg/mL) = Vial amount (mg) ÷ Diluent volume (mL)

Converting a milligram figure into a volume is the same relationship rearranged:

Volume (mL) = Desired amount (mg) ÷ Concentration (mg/mL)

Because both formulas share the same concentration term, they can be collapsed into one step: volume = (desired mg × diluent mL) ÷ vial mg. The calculator keeps them separate because seeing the concentration explicitly makes errors much easier to spot.

Converting volume into syringe units

Insulin syringes are marked in units rather than millilitres. The near-universal standard is U-100, where 100 units correspond to 1 mL. That gives a fixed conversion independent of the peptide:

Syringe units = Volume (mL) × 100

So 0.4 mL is 40 units, 0.25 mL is 25 units and 0.08 mL is 8 units. On a 0.3 mL syringe the barrel is marked to 30 units, on a 0.5 mL syringe to 50 units and on a 1 mL syringe to 100 units — the unit spacing is identical, only the total capacity differs. A unit is a volume marking, never a quantity of peptide: 10 units of a 5 mg/mL solution and 10 units of a 2.5 mg/mL solution contain different milligram amounts.

Worked mathematical examples

The following are arithmetic illustrations of the formulas above using hypothetical numbers. They are not dosing suggestions and carry no clinical meaning.

Example 1 — 10 mg vial, 2 mL diluent

Concentration = 10 mg ÷ 2 mL = 5 mg/mL
Volume for 2 mg = 2 ÷ 5 = 0.4 mL
Syringe units = 0.4 × 100 = 40 units
Portions of 2 mg = 10 ÷ 2 = 5
Remaining after 2 portions = 10 − 4 = 6 mg (1.2 mL)

Example 2 — same vial, 4 mL diluent

Concentration = 10 ÷ 4 = 2.5 mg/mL
Volume for 2 mg = 2 ÷ 2.5 = 0.8 mL
Syringe units = 80 units — will not fit a 0.5 mL syringe

Identical milligrams, double the volume. Only the dilution changed.

Example 3 — 30 mg vial, 3 mL diluent

Concentration = 30 ÷ 3 = 10 mg/mL
Volume for 1.5 mg = 1.5 ÷ 10 = 0.15 mL = 15 units
Portions of 1.5 mg = 30 ÷ 1.5 = 20

Example 4 — a non-whole result

Concentration = 15 mg ÷ 2 mL = 7.5 mg/mL
Volume for 4 mg = 4 ÷ 7.5 = 0.5333 mL ≈ 53.33 units
Portions of 4 mg = 15 ÷ 4 = 3.75 → 3 whole portions, 3 mg left over

Not every combination divides evenly. The calculator reports the exact fractional value and the number of whole portions separately rather than hiding the remainder.

mg vs mL vs syringe units

Milligram (mg) — a mass. It describes how much peptide is present and does not change when you add water.
Millilitre (mL) — a volume. It describes how much liquid is in the syringe and says nothing about how much peptide that liquid contains.
Syringe unit — a marking on a U-100 barrel equal to 1/100 mL. It is a volume label, not a mass.

Concentration is the only bridge between mass and volume. Any statement of the form "X units equals Y mg" is meaningless unless the mg/mL concentration is stated alongside it.

Common calculation mistakes

Treating units as milligrams. The single most frequent error. Units measure volume; milligrams depend entirely on concentration.
Using the label volume instead of the volume actually added. If you intended 2 mL but drew 1.8 mL, every subsequent figure is wrong. Enter what you really added.
Assuming dilution changes the total. More water does not create more peptide; a 10 mg vial holds 10 mg at any dilution.
Mixing micrograms and milligrams. 1 mg = 1000 mcg. Convert before entering values; this calculator works in milligrams.
Reading a non-U-100 syringe as U-100. U-40 and 3 mL luer-lock syringes use different markings entirely.
Over-rounding early. Rounding the concentration before dividing compounds the error. The calculator carries full precision internally and rounds only for display.

Important limitations

The calculator assumes the diluent volume you enter is the final solution volume and that the peptide dissolves completely and uniformly. In reality the dry powder contributes a small, usually negligible volume of its own, and residual liquid clings to the vial walls and needle hub, so the last portion in a vial is often slightly short of the theoretical figure. Vial fill quantities also carry manufacturing tolerance, and material sold as research chemical is not subject to pharmaceutical-grade content verification — the milligram figure printed on a label is an assumption, not a measurement.

Results are therefore only as accurate as the inputs. Nothing on this page evaluates suitability, safety or appropriateness for any person or purpose. See our medical disclaimer for the full scope of what this site does and does not do.

Retatrutide's research and development status

Retatrutide (LY3437943) is an investigational single-molecule triple agonist at the GIP, GLP-1 and glucagon receptors, developed by Eli Lilly and Company. In a phase 2 randomised, double-blind, placebo-controlled trial in adults with obesity published in the New England Journal of Medicine in 2023 (Jastreboff et al.), participants receiving the highest doses experienced substantially greater mean body-weight reduction than placebo over 48 weeks, with gastrointestinal adverse events the most commonly reported side effects. A separate phase 2 trial in adults with type 2 diabetes (Rosenstock et al., The Lancet, 2023) reported reductions in HbA1c and body weight.

As of this page's last update, retatrutide remains in phase 3 development (the TRIUMPH programme registered on ClinicalTrials.gov) and has not received marketing authorisation from the FDA, EMA or MHRA for any indication. There is no approved product label, no approved dosing schedule and no pharmacy-dispensed formulation. Material sold online is not an approved medicine. This context is provided as factual background only.

For mechanism, half-life, reported effects and evidence grading, see the full Retatrutide profile.

Peptide Reconstitution Calculator — the generic mg, mL and syringe-unit calculator that works for any peptide vial.
Retatrutide profile — mechanism of action, half-life, administration, side effects and evidence grade.
Retatrutide vs tirzepatide — open the comparison table with retatrutide preloaded and add tirzepatide.
Retatrutide vs semaglutide — same table, comparing the triple agonist against the GLP-1 mono-agonist.
Reconstitution guide — the general mixing and concentration maths behind this calculator.
Peptide database — every profile on the site, searchable by category and evidence grade.

Sources & references

Jastreboff AM, et al. Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial. N Engl J Med. 2023;389:514–526.
Rosenstock J, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo- and active-controlled, parallel-group, phase 2 trial. Lancet. 2023;402:529–544.
ClinicalTrials.gov — retatrutide (LY3437943) trial records, including the phase 3 TRIUMPH programme.
U.S. Food and Drug Administration — Drugs@FDA approved products database (no retatrutide entry).
Eli Lilly and Company — investigational pipeline disclosures for LY3437943.

Educational and mathematical content only. Nothing here is medical advice or a dosing recommendation.

Retatrutide Calculator